Abstract mRNA vaccines have emerged as highly effective strategies in the prophylaxis and
treatment of diseases, thanks largely although not totally to their extraordinary performance …

The interest in therapeutic cancer vaccines has caught enormous attention in recent years
due to several breakthroughs in cancer research, among which the finding that successful …

Abstract mRNA vaccines have gained popularity over the last decade as a versatile tool for
develo** novel therapeutics. The recent success of coronavirus disease (COVID-19) …

Immunotherapy as a treatment for cancer is a growing field of endeavor but reports of
success have been limited for epithelial ovarian cancer. Overcoming the challenges to …

Cancer immunotherapy has been proposed as a powerful treatment modality. Active
immunotherapy aspires to stimulate the patient's immune system, particularly T cells. These …

Immunotherapy with checkpoint inhibitors has changed the paradigm of treatment for many
tumors, and endometrial carcinoma is not an exception. Approved treatment options are …

Over the last two decades, dendritic cell (DC) vaccination has been studied extensively as
active immunotherapy in cancer treatment and has been proven safe in all clinical trials both …

Ovarian cancer (OC) is one of the most lethal malignant gynecologic tumors, characterized
by an uncertain presentation and poor outcomes. With or without neoadjuvant …

Gold nanoparticles (NPs) have been proposed as a highly potential tool in immunotherapies
due to its advantageous properties including customizable size and shapes, surface …

Simple Summary With an overall 5-year survival of only 20% for advanced-stage ovarian
cancer patients, enduring and effective therapies are a highly unmet clinical need. Current …